Evaluation of anti-tumor necrosis factor levels and anti-tumor necrosis factor antibodies in rheumatic diseases treated with infliximab and adalimumab; preliminary results from a local registry.
Fiche du document
Date
4 novembre 2014
Discipline
Type de document
Périmètre
Identifiants
- 10261/104294
- e-issn: 1529-0131
- issn: 0004-3591
- Arthritis and Rheumatism 63(Supl. 10): 2211 (2011)
Source
Organisation
Licence
none
Sujets proches
Blood--Serum Blood serumCiter ce document
J. Rosas et al., « Evaluation of anti-tumor necrosis factor levels and anti-tumor necrosis factor antibodies in rheumatic diseases treated with infliximab and adalimumab; preliminary results from a local registry. », Digital.CSIC (SHS)
